By Carolina Bolado (June 3, 2021, 9:47 PM EDT) -- Consumers suing drugmakers and others in a multidistrict litigation over a carcinogen found in heartburn medication Zantac fought Thursday in Florida federal court to keep their claims alive as the defendants argued their claims lacked specificity or an actual injury.
In a hearing before U.S. District Judge Robin L. Rosenberg on various motions to dismiss, the makers of Zantac told the court the consumers who used the drug or its generic equivalent ranitidine and have filed economic loss claims have not suffered any injury.
They bought a drug to treat a condition — in this case heartburn — and were not...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!